Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 30;97(11):e00771-23. doi: 10.1128/jvi.00771-23

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Bartsch et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

PMC Copyright notice

Fig 6 — PLS-R analysis of humoral and Fc-effector responses. PLS-R analysis was used to profile humoral and Fc-effector responses for participants receiving Ad26.RSV.preF alone (n = 8), RSV preF protein alone (n = 8), or the Ad26.RSV.preF/RSV preF protein combination vaccine (n = 15). Ad26, adenovector type 26; ADCD, antibody-dependent complement deposition; ADCP, antibody-dependent cellular phagocytosis; ADNP, antibody-dependent neutrophil phagocytosis; FcαR, Fcα receptor; FcγR, Fcγ receptor; IFN-γ, interferon-γ; Ig, immunoglobulin; LV, latent variable; MIP, macrophage inflammatory protein; PLS-R, partial least squares regression; preF, pre-fusion conformation-stabilized RSV F protein; RSV, respiratory syncytial virus.